Demand for GLP-1 improves the capacity utilisation of fill-finish capabilities offered by CDMOs While GLP-1 manufacturers are investing significantly in the development of the drug, few have the capacity to complete filling and packaging in-house
Wide Price Gap: Innovator vs Generics Innovator brands (Novo Nordisk Ozempic / Wegovy) 2,200 4,100 per week ~8,800 16,400+ per month depending on dose Earlier even higher (17,00035,000/month range) Indian generic brands (as shown in your image) As low as 322 550/week (vials) Mid-range 450 1,050/week (pens) Premium Indian brands ~900 2,000/week This shows up to 7080% lower pricing vs innovator brands 2
Even in mice that did not have any tumors, we found this deleterious effect of the combination, underscoring that it is not dependent on the presence of a tumor, said the authors
doi: 10.1016/j.ijbiomac.2024.131915 164 FengYChenSSongYLiuSDuanYCaiMet al
Novo Nordisk had to limit the lower starting doses of Wegovy so it could keep supplying patients already on higher maintenance doses of the drug